Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-002366

← back to feed
Filed
Sep 27, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Sep 25, 2021 160.79M sh
Current Liabilities Q1 2021 · Mar 31, 2021 $10.72M
Current Liabilities Q1 2021 · Dec 31, 2020 $10.45M
Total Liabilities Q1 2021 · Mar 31, 2021 $10.72M
Total Liabilities Q1 2021 · Dec 31, 2020 $10.45M
Current Assets Q1 2021 · Mar 31, 2021 $257.75K
Current Assets Q1 2021 · Dec 31, 2020 $50.92K
Total Assets Q1 2021 · Mar 31, 2021 $3.2M
Total Assets Q1 2021 · Dec 31, 2020 $3.04M
Net Income Q1 2021 · Mar 31, 2021 −$105.93K
Net Income Q1 2021 · Mar 31, 2020 −$23.39K
Stockholders Equity Q1 2021 · Dec 31, 2020 −$7.41M
Stockholders Equity Q1 2021 · Mar 31, 2020 −$6.95M
Stockholders Equity Q1 2021 · Dec 31, 2019 −$6.91M
Shares Diluted Q1 2021 · Mar 31, 2020 160.79M sh
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$54.38K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $14.09K
Cash And Equivalents Q1 2021 · Dec 31, 2019 $61.75K
Operating Income Q1 2021 · Mar 31, 2020 −$96.22K
Gross Profit Q1 2021 · Mar 31, 2020 −$15.4K
Cost Of Revenue Q1 2021 · Mar 31, 2020 $55.19K
Revenue Q1 2021 · Mar 31, 2020 $39.78K